P53 expression in placentas with hydropic change and hydatidiform moles

Modern Pathology

Volumn 9, Issue 4, 1996, Pages 392-396

  Cheville, John C ^a,b   Robinson, Robert A ^a   Benda, Jo A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b West Allis Hospital   (United States)

Author keywords

Hydatidiform mole; Hydropic change; Neoplasm; P53

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLACENTA DISORDER; PRIORITY JOURNAL;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; HYDATIDIFORM MOLE; HYDROPS FETALIS; IMMUNOHISTOCHEMISTRY; PLACENTA; PLACENTA DISEASES; PREGNANCY; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 0029990186     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Szulman AE, Surti U: The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 131:665, 1978
2. Szulman AE, Surti U: The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 132:20, 1978
3. Teng NNM, Ballon SC: Partial hydatidiform mole with diploid karyotype: Report of three cases. Am J Obstet Gynecol 150:961, 1984
4. Ohama K, Ueda K, Okamoto M, Takemata M, Fujiwara A: Cytogenetic and clinicopathologic studies of partial moles. Obstet Gynecol 68:259, 1986
5. Berkowitz RS, Goldstein DP, Bernstein MR: Natural history of partial molar pregnancy. Obstet Gynecol 66:677, 1985
6. Mostoufi-Zadeh M, Berkowitz RS, Driscoll SG: Persistence of partial mole. Am J Clin Pathol 87:377, 1987
7. Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR: Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 36:358, 1990
8. Szulman AE, Surti U: The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol 59:597, 1982
9. Wong LC, Ma HK: The syndrome of partial mole. Arch Gynecol 234:161, 1984
10. Vejerslev LO, Fisher RA, Surti U, Wake N: Hydatidiform mole: Cytogenetically unusual cases and their implications for the present classification. Am J Obstet Gynecol 157:180, 1987
11. Lage JM, Weinberg DS, Yavner DL, Bieber FR: The biology of tetraploid hydatidiform moles: Histopathology, cytogenetics and flow cytometry. Hum Pathol 20:419, 1989
12. Bagshawe KD, Wilson H, Dublon P, Smith A, Baldwin M, Kardana A: Follow-up after hydatidiform mole: Studies using radioimmunoassay for urinary human chorionic gonadotropin (HCG). J Obstet Gynaecol Br Commonwealth 80:461, 1973
13. Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT: Hydatidiform mole: Diagnosis, management and long-term follow-up of 347 patients. Obstet Gynecol 59:75, 1982
14. Lurain JR, Brewer JI, Torok EE, Halpern B: Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145:591, 1983
15. Fox H: Hydatidiform moles. Virchows Arch A Pathol Anat Histopathol 415:387, 1989
16. Suresh UR, Chawner L, Buckley GH, Fox H. Do AgNOR counts reflect cellular ploidy or cellular proliferation? A study of trophoblastic tissue. J Pathol 160:213, 1990
17. Cheung ANY, Srivastava G, Pattaluga S, Man TK, Ngan H, Collins RJ: Expression of c-myc and c-fms oncogenes in trophoblastic cells of hydatidiform mole and normal human placenta. J Clin Pathol 46:204, 1993
18. McBride DW, Merry D, Givol D: The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A 83:130, 1986
19. Isobe M, Emanuel BS, Givol D, et al.: Localization of gene for human p53 tumor antigen to band 17p13. Nature 320:84, 1986
20. Oren M: p53: The ultimate tumor suppressor gene? FASEB J 6:3169, 1992
21. Porter PL, Gown AM, Dramp SG, et al.: Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methamine-fixed, embedded tissue. Am J Pathol 140:145, 1992
22. Nigro JM, Baker SJ, Preisinger AC, et al.: Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705, 1989
23. Bruner JM, Connelly JH, Saya H: p53 Protein immunostaining in routinely processed paraffin-embedded sections. Mod Pathol 16:189, 1993
24. Finlay CA, Hinds PW, Tan TH, et al.: Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 8:531, 1988
25. Ambros RA, Ross JS, Kallakury BVS, et al.: p53 Gene status in endometrial carcinomas showing diffuse positivity for p53 protein by immunohistochemical analysis. Mod Pathol 8:441, 1995
26. Cheville JC, Greiner T, Robinson RA, Benda JA: Ploidy analysis by flow cytometry and FISH in hydropic placentas and gestational trophoblastic disease. Hum Pathol 26:753, 1995
27. Hsu SM, Raine L, Fanger H: A use of avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 75:816, 1981
28. Shi SR, Key ME, Kalva KL:. Antigen retrieval in formalin-fixed paraffin-embedded tissues: An enhancement method for immuno-histochemical staining based on microwave heating of tissue sections. J Histochem Cytochem 39:741, 1991
29. Martinez J, Georgoft I, Levine AJ: Cellular localization and cell cycle regulation by a temperature-sensitive mutant of p53. Genes Dev 5:151, 1991
30. Hollstein M, Disransky D, Vogelstein B, Harris CC: p53 Mutations in human cancers. Science 253:49, 1991
31. Roncalli M, Bulfamante G, Viale G, et al.: c-myc and tumour suppressor gene product expression in developing and term human trophoblast. Placenta 18:399, 1994
32. Schmid P, Lorenz A, Hameister H, Montenarh M: Expression of p53 during mouse embryogenesis. Development 113:857, 1991
33. Cheville JC, Robinson RA, Benda JA: Evaluation of Ki-67 (MIB-1) staining in placentas with hydropic change and partial and complete hydatidiform moles. Pediatr Pathol Lab Med 16:41, 1996
34. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13, 1985
35. Verhuijen R, Kuijpers HJH, Schlengemann RO, et al.: Ki-67 detects nuclear matrix-associated proliferation-related antigen: Intracellular localization during interphase. J Cell Sci 92:123, 1989
36. Schwarting R, Gerdes J, Nichus J, Jaexch C, Stein H: Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 90:365, 1986
37. Celis JE, Celis A: Cell cycle dependent variations in the distribution of the nuclear protein cyclin: Proliferating cell nuclear antigen in cultured cells. Subdivision of S-phase. Proc Natl Acad Sci U S A 82:3262, 1985
38. Adamson ED: Expression of proto-oncogenes in the placenta (review article). Placenta 8:449, 1987
39. Pollard JW, Bartocci A, Arceci R, et al.: Apparent role of the macrophage growth factor CSF-1, in placental development. Nature 330:484, 1987
40. Sheer CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor CSF-1. Cell 41:665, 1985
41. Hoshina M, Hishio A, Bo M, Boime I, Mochizuki M: The expression of oncogene fms in human chorionic tissue. Acta Obstet Gynecol Jpn 37:2791, 1985
42. Pfeifer-Ohlsson SB, Goustin AS, Rydnert J, et al.: Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: Implications for embryonic cell proliferation. Cell 38:585, 1984